TGFB1 and neoplasm: However, TGF-β signaling induced by caALK5 expression should remain unchanged upon 1D11 treatment, allowing TGF-β signaling inhibition specifically in the tumor microenvironment, while keeping TGF-β signaling active in tumor cells.